Trastuzumab Emtansine
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea (NCT06928818) | Seoul National University Hospital | 2025-02-26 |
| Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy (NCT06125834) | The First Affiliated Hospital with Nanjing Medical University | 2023-06-01 |
Track Trastuzumab Emtansine automatically
Every clearance here is in the API, with alerts when new ones post.